李雷, 马水清. 盆腔放线菌病[J]. 协和医学杂志, 2020, 11(1): 68-72. DOI: 10.3969/j.issn.1674-9081.20170122
引用本文: 李雷, 马水清. 盆腔放线菌病[J]. 协和医学杂志, 2020, 11(1): 68-72. DOI: 10.3969/j.issn.1674-9081.20170122
Lei LI, Shui-qing MA. Pelvic Actinomycosis[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 68-72. DOI: 10.3969/j.issn.1674-9081.20170122
Citation: Lei LI, Shui-qing MA. Pelvic Actinomycosis[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 68-72. DOI: 10.3969/j.issn.1674-9081.20170122

盆腔放线菌病

Pelvic Actinomycosis

  • 摘要: 盆腔放线菌病是罕见的生殖道感染性疾病, 绝大部分女性患者携带宫内节育器。患者可能伴有发热、腹痛、分泌物增加、盆腔包块等并不特异的临床症状和表现, 诊断高度依赖组织病理学和微生物学, 微生物学目前在诊断中发挥了重要作用。药物治疗是基础和首选。手术切除感染组织用于严重的坏死组织、窦道形成或瘘形成。患者总体预后较好。

     

    Abstract: Pelvic actinomycosis is a rare infectious disease involving the female reproductive tract. Most of the patients carry an intrauterine device, having some non-specific clinical symptoms and manifestations such as fever, abdominal pain, discharge, and pelvic mass. The diagnosis of actinomycosis highly depends on discoveries of pathology and microbiology. Drug therapy is a basic choice of treatment. Surgeries were applied to severe necrosis and formation of sinus or fistula. Generally, patients with pelvic actinomycosis have a good prognosis.

     

/

返回文章
返回